These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3045442)

  • 1. Luminol-enhanced chemiluminescence of peripheral blood leukocytes as an early indicator of graft take after allogeneic bone marrow transplantation in patients with acute myelogenous leukaemia.
    Rajamäki A; Lilius EM; Nikoskelainen J; Proskin J; Salmi TT; Toivanen A
    Med Oncol Tumor Pharmacother; 1988; 5(2):99-102. PubMed ID: 3045442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophils are responsible for the reappearance of chemiluminescence after allogeneic bone marrow transplantation.
    Leino L; Lilius EM; Nikoskelainen J; Pelliniemi TT; Rajamäki A
    Bone Marrow Transplant; 1990 Dec; 6(6):391-4. PubMed ID: 2097006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of non-opsonized zymosan-induced and luminol-enhanced chemiluminescence in whole blood and isolated phagocytes.
    Lindena J; Burkhardt H; Dwenger A
    J Clin Chem Clin Biochem; 1987 Nov; 25(11):765-78. PubMed ID: 3440857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luminol-dependent chemiluminescence analysis of the variables of the phagocytic response by canine granulocytes.
    Angle MJ; Klesius PH
    Vet Immunol Immunopathol; 1983 Apr; 4(3):333-44. PubMed ID: 6868336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminol-dependent chemiluminescence microassay for phagocytic function.
    Thomas VL; Sanford BA; Driscoll MS; Casto DT; Ramamurthy RS
    J Immunol Methods; 1988 Jul; 111(2):227-32. PubMed ID: 3397547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation.
    Stockschläder M; Hassan HT; Krog C; Krüger W; Löliger C; Horstman M; Altnöder M; Clausen J; Grimm J; Kabisch H; Zander A
    Br J Haematol; 1997 Feb; 96(2):382-6. PubMed ID: 9029030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced alveolar cell luminol-dependent chemiluminescence in asthma.
    Cluzel M; Damon M; Chanez P; Bousquet J; Crastes de Paulet A; Michel FB; Godard P
    J Allergy Clin Immunol; 1987 Aug; 80(2):195-201. PubMed ID: 3611540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children.
    Weisdorf DJ; McGlave PB; Ramsay NK; Miller WJ; Nesbit ME; Woods WG; Goldman AI; Kim TH; Kersey JH
    Br J Haematol; 1988 Jul; 69(3):351-8. PubMed ID: 3044439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of luminol-dependent chemiluminescence reactivity of peripheral blood leukocytes from patients with lymphoreticular tumor, solid cancer, or healthy blood donors by interferon-alpha.
    Müller S; Krasner J; Ozer H; Blumenson L
    J Interferon Res; 1987 Feb; 7(1):1-15. PubMed ID: 3585077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
    Dini G; Boni L; Abla O; Uderzo C; Polchi P; Locatelli F; Di Bartolomeo P; Arcese W; Iori AP; Rossetti F
    Bone Marrow Transplant; 1994 Jun; 13(6):771-6. PubMed ID: 7920313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced eosinophil luminol-dependent chemiluminescence in allergic rhinitis.
    Shult PA; Graziano FM; Busse WW
    J Allergy Clin Immunol; 1986 May; 77(5):702-8. PubMed ID: 3700895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemiluminescence of polymorphonuclear leukocytes and whole blood during acute bacterial infection.
    Pauksens K; Sjölin J; Venge P
    Scand J Infect Dis; 1989; 21(3):277-84. PubMed ID: 2756341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous detection of native and luminol-dependent luminescence of stimulated human polymorphonuclear leukocytes.
    Roschger P; Graninger W; Klima H
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1047-53. PubMed ID: 6487320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luminol-enhanced chemiluminescence of whole blood. Statistical analysis, and comparison of the responses of different subjects.
    Ristola M; Repo H
    APMIS; 1989 Jun; 97(6):503-12. PubMed ID: 2736103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen-derived free radicals producing activity and survival of activated polymorphonuclear leukocytes.
    Prasad K; Chaudhary AK; Kalra J
    Mol Cell Biochem; 1991 Apr; 103(1):51-62. PubMed ID: 1857345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation for children with acute myelogenous leukaemia in the first complete remission.
    Matsuyama T; Horibe K; Kato K; Kojima SS
    Eur J Cancer; 2000 Feb; 36(3):368-75. PubMed ID: 10708939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia.
    Kumar S; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Litzow MR
    Bone Marrow Transplant; 2001 Nov; 28(10):951-6. PubMed ID: 11753550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia.
    Matsubara H; Makimoto A; Takayama J; Higa T; Saito T; Kanda Y; Tanosaki R; Mineishi S; Ohira M; Takaue Y
    Jpn J Clin Oncol; 2001 Jan; 31(1):30-4. PubMed ID: 11256838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.